Combined Index to USP 38 and NF 33, Including First Supplement The

Combined Index to USP 38 and NF 33, Including First Supplement The

Combined Index to USP 38 and NF 33, including First Supplement The following Index is for convenience and informational use only and shall not be used for interpretive purposes. In addition to official articles, this Index may also include items recently omitted from the USP–NF in the indicated Book or Supplement. The requirements stated in the General Notices and Requirements section of the USP–NF apply to all articles recognized in the USP–NF and to all general chapters unless specifically stated otherwise. Although this revision (USP 38–NF 33) is generally official beginning May 1, 2015, particular provisions may indicate another earlier or later official date. In addition, the monographs and general chapters listed in this Index may reference other general chapter specifications. The articles listed in this Index are not intended to be autonomous standards and should only be interpreted in the context of the entire USP–NF publication. For the most current version of the USP–NF please see the USP–NF Online and Official Text section of the USP Website. Combined Index to USP 38 and NF 33 Abaca-Aceto I-1 Combined Index to USP 38 and NF 33, including First Supplement Page citations refer to the pages of Volumes 1, 2, 3, 4 of USP 38±NF 33 and its First Supplement. This index is repeated in its entirety in each volume. 1±1994 Volume 1 1995±3998 Volume 2 3999±5864 Volume 3 5865±6956 Volume 4 6957±7484 First Supplement Numbers in angle brackets such as 〈421〉 refer to chapter numbers in the General Chapters section. and (salts of) chlorpheniramine, and oxycodone capsules, 4711 A dextromethorphan, and and oxycodone tablets, 4712 phenylpropanolamine, oral solution and pentazocine tablets, 4803 Abacavir containing at least three of the and propoxyphene hydrochloride tablets, oral solution, 1995 following, 2016 5051 sulfate, 1996 and (salts of) chlorpheniramine, and propoxyphene napsylate tablets, 5056 tablets, 1997 dextromethorphan, and and pseudoephedrine hydrochloride Absolute phenylpropanolamine, tablets containing tablets, 2037 alcohol, 1815 at least three of the following, 2018 oral solution, 2007 ether, 1814 and (salts of) chlorpheniramine, for effervescent oral solution, 2007 Absorbable dextromethorphan, and suppositories, 2008 dusting powder, 3250 pseudoephedrine, capsules containing at oral suspension, 2008 gelatin film, 3657 least three of the following, 2020 tablets, 2009 gelatin sponge, 3657 and (salts of) chlorpheniramine, extended-release tablets, 2010 surgical suture, 5420 dextromethorphan, and and tramadol hydrochloride oral Absorbent pseudoephedrine, oral powder suspension, 5636 cotton, 1814 containing at least three of the and tramadol hydrochloride tablets, 2038 gauze, 3655 following, 2022 Acetanilide, 1814 odorless paper, 1854 and (salts of) chlorpheniramine, Acetate Acacia, 6503 dextromethorphan, and methyl, 1849 syrup, 6503 pseudoephedrine, oral solution Acetate buffer, 1885 Acarbose, 1999 containing at least three of the TS, 1886 Acebutolol hydrochloride, 2000, 7321 following, 2024 Acetazolamide, 2041 capsules, 2001 and (salts of) chlorpheniramine, for injection, 2041 Acepromazine maleate, 2002 dextromethorphan, and oral suspension, 2042 injection, 2003 pseudoephedrine, tablets containing at tablets, 2042 tablets, 2003 least three of the following, 2026 Acetic acid, 1814, 6505 Acesulfame potassium, 6504 chlorpheniramine maleate, and ammonium acetate buffer TS, 1886 Acetal, 1814 dextromethorphan hydrobromide diluted, 1814, 6505 Acetaldehyde, 1814 tablets, 2028 double-normal (2 N), 1894 TS, 1886 and codeine phosphate capsules, 2030 glacial, 1814, 2043 Acetaminophen, 2004 and codeine phosphate oral solution, 2031 glacial, TS, 1886 aspirin and caffeine tablets, 2012 and codeine phosphate oral suspension, and hydrocortisone otic solution, 3784 and aspirin tablets, 2011 2032 irrigation, 2044 butalbital and caffeine capsules, 2503 and codeine phosphate tablets, 2033 metaphosphoric, TS, 1890 butalbital and caffeine tablets, 2504 dextromethorphan hydrobromide, otic solution, 2044 and caffeine tablets, 2013 doxylamine succinate, and strong, TS, 1886 capsules, 2006 pseudoephedrine hydrochloride oral Acetic acid in peptides, 327 and (salts of) chlorpheniramine, solution, 2034 Acetic anhydride, 1814 dextromethorphan, and and diphenhydramine citrate tablets, 2035 Acetohexamide, 2044 phenylpropanolamine, capsules diphenhydramine hydrochloride, and tablets, 2045 containing at least three of the pseudoephedrine hydrochloride tablets, Acetohydroxamic acid, 2045 following, 2014 2036 tablets, 2046 and hydrocodone bitartrate tablets, 3776 Acetone, 1814, 6506 isometheptene mucate, and anhydrous, 1814 dichloralphenazone capsules, 3953 neutralized, 1814, 1886 I-2 Aceto-Alumi Combined Index to USP 38 and NF 33 Acetonitrile, 1814 Isoetharine mesylate inhalation, 3948 injection, 2086 spectrophotometric, 1814 Isoproterenol hydrochloride inhalation, Alfuzosin hydrochloride, 2086 Acetophenone, 1814 3960 extended-release tablets, 2088 p-Acetotoluidide, 1814 Isoproterenol hydrochloride and Alginates assay 〈311〉, 262 Acetylacetone, 1814 phenylephrine bitartrate inhalation, 3963 Alginic acid, 6514 Acetyl chloride, 1814 Isoproterenol sulfate inhalation, 3965 Alizarin complexone, 1816 Acetylcholine chloride, 1814, 2047 Lidocaine topical, 4095 Alkaline for ophthalmic solution, 2047 Metaproterenol sulfate inhalation, 4280 borate buffer, 1885 Acetylcysteine, 2048 Polymyxin B sulfate and bacitracin zinc cupric citrate TS, 1886 and isoproterenol hydrochloride inhalation topical, 4921 cupric citrate TS 2, 1886 solution, 2050 Povidone-iodine topical, 4957 cupric iodide TS, 1886 solution, 2049 Terbutaline sulfate inhalation, 5493 cupric tartrate TS, 1886 N-Acetylglucosamine, 5865 Thimerosal topical, 5545 mercuric-potassium iodide TS, 1886 3-Acetylthio-2-methylpropanoic acid, 1814 Tolnaftate topical, 5618 phosphatase enzyme, 1816 Acetyltributyl citrate, 6507 Triamcinolone acetonide topical, 5659 picrate TS, 1886 Acetyltriethyl citrate, 6507 Agar, 1815, 6509 pyrogallol TS, 1892 N-Acetyltyrosine, 5866 Agarose, 1815 sodium hydrosulfite TS, 1886 N-Acetyl-L-tyrosine ethyl ester, 1814 Air, medical, 2064 Alkyl (C12-15) benzoate, 6515 Acid Air-helium certified standard, 1815 Alkylphenoxypolyethoxyethanol, 1816 acrylic, 1815 Alanine, 2064, 7324 Allantoin, 2092 alpha lipoic, 6128 L-Alanyl-L-glutamine, 5867 Allopurinol, 2093 dehydroacetic, 6635 Albendazole, 2065 oral suspension, 2095 ferric chloride TS, 1886 oral suspension, 2066 tablets, 2095 ferrous sulfate TS, 1886 tablets, 2066 Allyl isothiocyanate, 2096 phthalate buffer, 1885 Albumen TS, 1886 Almond oil, 6515 stannous chloride TS, 1886 Albumin Almotriptan stannous chloride TS, stronger, 1886 bovine serum, 1815 tablets, 7328 Acid-neutralizing capacity 〈301〉, 261 human, 2067 Almotriptan Malate, 7325 Acidulated phosphate and sodium fluoride rAlbumin human, 6510 Aloe, 2096 topical solution, 5321 Albuterol, 2068 Alpha Acitretin, 2051 sulfate, 2071 lipoic acid, 6128 capsules, 2052 tablets, 2072 Alpha-chymotrypsin, 1816 Acoustic emission 〈1005〉, 699 extended-release tablets, 2068 Alpha cyclodextrin hydrate, 1816 Acrylic acid, 1815 Alclometasone dipropionate, 2073 Alpha-(2-(methylamino)ethyl)benzyl alcohol, Activated cream, 2074 1816 alumina, 1815 ointment, 2075 Alphanaphthol, 1816 charcoal, 1815, 2739 Alcohol, 1815, 2076 Alphazurine 2G, 1882 magnesium silicate, 1815 70 percent, 80 percent, and 90 percent, Alprazolam, 2097 Acyclovir, 2054 1815 oral suspension, 2098 capsules, 2055 absolute, 1815 tablets, 2099 for injection, 2055 aldehyde-free, 1815 extended-release tablets, 2100 ointment, 2056 alpha-(2-(methylamino)ethyl)benzyl, 1816 orally disintegrating tablets, 2104 oral suspension, 2057 amyl, 1815 Alprenolol hydrochloride, 1816 tablets, 2058 tert-amyl, 1818 Alprostadil, 2106 Adamantane, 1815 butyl, 6551 injection, 2108 Adapalene, 2059 dehydrated, 1815, 2078 Alteplase, 2109 Ademetionine disulfate tosylate, 6206 dehydrated isopropyl, 1815 for injection, 2112 Adenine, 2061, 7323 denaturated, 1815 Alternative microbiological sampling methods sulfate, 1815 denaturated, TS, 1888 for nonsterile inhaled and nasal products Adenosine, 2062 determination 〈611〉, 418 〈610〉, 416 injection, 2063 in dextrose injection, 2080 Altretamine, 2113 Adipic acid, 1815, 6508 diluted, 1815, 6512 capsules, 2113 Admissions injection, dehydrated, 2080 Alum, 1816 to NF 33, 6491 isobutyl, 1815 ammonium, 1816, 2114 to USP 38, xxxix, 6977 isopropyl, 1815 potassium, 1859, 2115 Advisory Groups, xxiv, 6976 methyl, 1815 Alumina, 1816 Aerosol neutralized, 1815 activated, 1816 Bacitracin and polymyxin B sulfate topical, phenol TS, 1886 anhydrous, 1816 2359 n-propyl, 1815 aspirin, codeine phosphate, and magnesia Benzocaine, butamben, and tetracaine rubbing, 2081 tablets, 2303 hydrochloride topical, 2391 secondary butyl, 1815 aspirin, and magnesia tablets, 2297 Benzocaine and menthol topical, 2394 tertiary butyl, 1815 aspirin, and magnesium oxide tablets, Benzocaine topical, 2388 Alcoholic 2298 Betamethasone dipropionate topical, 2417 ammonia TS, 1886 magnesia, and calcium carbonate Dexamethasone sodium phosphate mercuric bromide TS, 1886 chewable tablets, 2118 inhalation, 3038 potassium hydroxide TS, 1886 magnesia, calcium carbonate, and Dexamethasone topical, 3031 potassium hydroxide TS 2, 1891 simethicone chewable tablets, 2119 Epinephrine bitartrate inhalation, 3318 TS, 1886 magnesia, and calcium carbonate oral Epinephrine inhalation, 3315 Alcoholometric table, 1989 suspension, 2117 Ergotamine tartrate inhalation, 3336 Aldehyde dehydrogenase, 1815

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    70 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us